WWM
GILD icon

Walser Wealth Management’s Gilead Sciences GILD Stock Holding History

Walser Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$275K Buy
2,179
+274
+14% +$36.1K 0.11% 172
2026
Q1 		$265K Buy
1,905
+135
+8% +$18.9K 0.12% 142
2025
Q4 		$217K Buy
+1,770
New +$215K 0.11% 133

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Walser Wealth Management's GILD Position: Q2 2026 in Review

Walser Wealth Management increased its Gilead Sciences (GILD) stake by 14% in Q2 2026, buying an estimated $36.1K and bringing the position to 2,179 shares worth $275K. The position accounts for 0.11% of the portfolio, ranked #172.

Walser Wealth Management first reported a position in GILD in Q4 2025 and has held it in 3 quarters since. 2,261 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Walser Wealth Management held 2,179 shares of Gilead Sciences worth $275K as of Q2 2026.
  • Walser Wealth Management bought 274 Gilead Sciences shares in Q2 2026, an estimated $36.1K.
  • Gilead Sciences made up 0.11% of Walser Wealth Management's portfolio in Q2 2026, its #172 holding.
  • Walser Wealth Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 3 quarters since.
  • 2,261 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Walser Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.